Dimethylacetamide-induced Hepatic Injury in Vitro: Mechanism and Potential Preventive Strategy

Area of Science:

• Toxicology
• Hepatology
• Molecular Biology

Background:

• N,N-Dimethylacetamide (DMAc) is a common industrial solvent with known, yet incompletely understood, hepatotoxicity.
• Limited data exists on the precise pathogenic mechanisms of DMAc-induced liver injury.
• Occupational exposure necessitates a deeper understanding of DMAc's effects on liver health.

Purpose of the Study:

• To investigate the toxic effects of DMAc on human normal hepatocytes (LO-2).
• To elucidate the molecular mechanisms underlying DMAc-induced hepatic cell injury.
• To explore potential prophylactic measures against DMAc toxicity.

Main Methods:

• Utilized human normal hepatocytes (LO-2) as an in vitro model.
• Employed a series of molecular biology measurements to assess cellular damage.
• Analyzed the role of reactive oxygen species (ROS) and the Bcl-2 pathway.
• Evaluated the protective effects of glutathione (GSH) and vitamin C (Vit C).

Main Results:

• DMAc induced LO-2 cell apoptosis in a dose-dependent manner.
• Increased ROS generation and Bcl-2 pathway activation were key mediators of DMAc toxicity.
• Glutathione (GSH) partially inhibited DMAc-induced apoptosis.
• Vitamin C (Vit C) did not show significant protective effects.

Conclusions:

• DMAc triggers hepatocyte apoptosis via ROS generation and Bcl-2 pathway modulation.
• Glutathione (GSH) demonstrates potential as an effective prophylactic agent for workers exposed to DMAc.
• Further research into GSH's protective role is warranted for occupational health strategies.